Home > Boards > US Listed > Medical - Drugs > Athenex (ATNX)

DCTH acquisition/strategic partnership with ATNX imminent

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Leotrader211 Member Profile
 
Followed By 3
Posts 504
Boards Moderated 0
Alias Born 09/18/17
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 5/15/2019 6:16:48 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 8:40:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 7:06:45 AM
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/9/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2019 5:06:58 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/8/2019 4:55:40 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 5/8/2019 4:02:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2019 8:06:56 AM
Athenex Announces $100 Million Private Placement GlobeNewswire Inc. - 5/6/2019 8:00:00 AM
Athenex Announces Promising Early and Complete Response Data from a Clinical Study of Oraxol in Cutaneous Angiosarcoma GlobeNewswire Inc. - 5/3/2019 9:12:18 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/25/2019 4:11:44 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/25/2019 7:03:49 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/25/2019 7:02:03 AM
Athenex, Inc. to Report First Quarter 2019 Earnings Results on May 9, 2019 GlobeNewswire Inc. - 4/25/2019 7:00:00 AM
Athenex Announces Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting GlobeNewswire Inc. - 4/23/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/17/2019 4:26:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/17/2019 4:23:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/17/2019 4:20:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/17/2019 4:15:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/17/2019 4:11:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2019 4:28:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2019 4:25:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2019 4:21:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2019 4:11:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2019 4:30:06 PM
Leotrader211   Friday, 02/02/18 07:03:48 AM
Re: JJAAMMAANN post# 4
Post # of 14 
DCTH acquisition/strategic partnership with ATNX imminent

The Prospects are looking very very good. The question I have is when would an acquirer like Athenex enter into strategic partnership with a company like DCTH for a majority stake, on whose Board their Chief Strategy Officer sits. At the time when the price is still very very low, while the prospect from trial perspective looking very very high or whem the successful trial results are baked in pps? Logical answer is former i.e. now. All the results and reports are already in front of ATNX via Pedder. ATNX Equity financing is roughly 60M now complete and for a Company like ATNX that has over a billion dollar market cap, spending 10 to 20 Million to get a majority stake in DCTH is like spending loose change cor synergies mentioned earlier. 

The other recent acquisitions by ATNX of QuaDPharma, Polymed Therapeutics, Comprehensive Drug Enterprises, to name a few, had somewhat similar process. 

I have not seen anything so far contrary to my hypothesis. 

We shall see the PR coming out latest by next week, if not today. 

Good things come to those who wait. 

Cheers! 

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist